Clinical Overview

Left atrial hypertrophy (LAH) is an anatomic diagnosis: thickening of the left atrial muscular wall, most often as a compensatory response to a sustained pressure or volume load the chamber has to work against (Left Atrial Hypertrophy, Primary Care Notebook/GPnotebook; Left Atrial Enlargement, LITFL, 2024). It is one of two mechanisms grouped under the broader “left atrial enlargement” umbrella — wall thickening (hypertrophy) versus chamber stretching (dilation) — and the literature does not always separate them cleanly, since a chamber under sustained load can do either or both (Left Atrial Enlargement, StatPearls, Parajuli, Alahmadi & Ahmed, updated 2025). Because a surface ECG cannot tell a thickened wall from a dilated cavity apart, the 2009 AHA/ACCF/HRS scientific statement on ECG standardization recommends “atrial abnormality” as the more accurate umbrella term for the P-wave pattern this finding produces, rather than “hypertrophy,” “enlargement,” “overload,” or “P mitrale” (Surawicz et al., Circulation, 2009, as cited by Primary Care Notebook/GPnotebook). This page covers LAH as the anatomic, muscle-thickening diagnosis; the ECG pattern this finding is presumed to produce — a widened, notched P wave, often called P mitrale — is this dataset’s separate “Prolonged P Wave” (PPW) label and page, and Left Atrial Enlargement (LAE) is this dataset’s separate label most often applied to chamber dilation. In this dataset’s record labels, LAH and LAE are applied as mutually exclusive tags — no record carries both — the same pattern seen between this dataset’s right-sided hypertrophy and enlargement labels, and consistent with each tag reflecting the interpreting clinician’s original term choice rather than a distinguishable ECG feature (search-index.json record data, this dataset). LAE is also a strikingly rare label in this dataset — one matching record against LAH’s eight — so most of this dataset’s left-atrial-pressure-load findings were read and recorded as LAH rather than LAE. Unlike this dataset’s RAH-TPW pairing, where most RAH-labeled records also carry the tall-P-wave sign label, none of the eight LAH-labeled records in this dataset separately carry the PPW sign label; with a sample this small that absence should not be read as disproving any clinical relationship between the two, only as a real pattern in how this dataset’s labels happen to have been applied (search-index.json record data, this dataset). A strip carrying this dataset’s LAH label is asserting a P-wave pattern historically read as suggesting left atrial hypertrophy, not a confirmed anatomic finding on imaging.

Mechanistically, the P wave’s first half reflects right atrial depolarization and its second half reflects left atrial depolarization, which starts slightly later because the impulse must first cross the interatrial conduction pathways, principally Bachmann’s bundle (P Wave, StatPearls, Douedi & Douedi, updated 2023). When left atrial muscle thickens under sustained pressure or volume load, that later, larger left atrial component takes even longer to complete, so total atrial activation time lengthens and the P wave widens and often becomes notched in lead II, with a widened and deepened terminal negative deflection appearing in V1 as the delayed left atrial vector is directed away from that lead (P Wave, StatPearls, 2023; Left Atrial Enlargement, LITFL, 2024). This is close to the mechanistic opposite of right atrial hypertrophy, where the abnormality amplifies an early right atrial component without lengthening total conduction time, rather than stretching it out (P Wave, StatPearls, 2023). A comparatively pure example of pressure-driven left atrial change is isolated mitral stenosis: the narrowed valve raises left atrial pressure and forces the chamber to enlarge against that load, while the left ventricle, starved of the inflow it would need to hypertrophy, experiences impaired diastolic filling instead — mitral stenosis is classically cited as a cause of left atrial enlargement occurring in isolation, without the left ventricular hypertrophy that accompanies most of this finding’s other causes (Mitral Stenosis, StatPearls, updated 2026; Left Atrial Enlargement, LITFL, 2024). Most of this finding’s other recognized causes — systemic hypertension, aortic stenosis, mitral regurgitation, hypertrophic cardiomyopathy — load the left atrium together with the left ventricle, so a combined hypertrophy-and-dilation picture accompanied by left ventricular hypertrophy criteria is more typical than the mitral-stenosis example’s comparatively isolated pressure load (Left Atrial Enlargement, StatPearls, 2025; Left Atrial Enlargement, LITFL, 2024).

The ECG pattern associated with LAH correlates imperfectly with true anatomic wall thickening or enlargement confirmed on imaging. A 2025 single-center study of 1,000 patients found the lead II P-wave duration criterion had the strongest single-criterion correlation with echocardiography among the standard left atrial enlargement criteria (area under the curve of 0.81), while the V1 terminal-negative-deflection criterion performed distinctly weaker (area under the curve of 0.59); correlation with cardiac MRI was weaker again for both, and the authors concluded that current ECG criteria for left atrial enlargement need updating (Correlating Left Atrial Enlargement and Left Ventricular Hypertrophy on ECG With Echocardiography and Cardiac MRI, 2025). In practice this means the P-wave pattern is a reasonable prompt to investigate further, but it should not be treated as confirming or excluding true left atrial hypertrophy without echocardiographic correlation (2025 study, above).

LAH itself produces no symptoms directly — it is a structural finding, not a rhythm disturbance, and many cases are picked up incidentally (Left Atrial Enlargement, Cleveland Clinic, reviewed 2022). Any symptoms a patient reports — palpitations, an irregular heartbeat, shortness of breath, fatigue, or chest discomfort — come from the underlying condition driving the left atrial load, or from an arrhythmia the thickened chamber has helped sustain, not from the hypertrophy itself (Cleveland Clinic, 2022).

Causes center on whatever raises left atrial pressure or volume over time. Systemic hypertension and mitral valve disease (stenosis or regurgitation) are the most commonly cited drivers (Left Atrial Enlargement, StatPearls, 2025; Left Atrial Enlargement, LITFL, 2024). Left ventricular hypertrophy, diastolic dysfunction, aortic stenosis, and obesity are also recognized causes (Left Atrial Enlargement, StatPearls, 2025), and hypertrophic cardiomyopathy is a further recognized cause when it drives left ventricular hypertrophy (Left Atrial Enlargement, LITFL, 2024). Chronic atrial fibrillation is both a cause and a consequence: sustained AF promotes left atrial remodeling, and the resulting hypertrophy or dilation in turn makes the arrhythmia more likely to persist and to recur after treatment (Left Atrial Enlargement, StatPearls, 2025; Left Atrial Enlargement, LITFL, 2024).

Interpretation Guide

Key Features:

• Rate: not a defining feature — LAH is a chamber finding whose ECG correlate can appear at any underlying rate
• Rhythm: not a defining feature — the finding describes left atrial wall thickness, not rhythm origin or regularity, though it is a recognized substrate for atrial fibrillation
• P waves: the ECG correlate is a widened, often notched P wave — duration exceeding 120 ms in lead II, typically with an interpeak interval between the two notch components exceeding 40 ms, plus a widened (>40 ms) and deepened (>1 mm) terminal negative deflection in V1 — with P-wave amplitude staying within the normal range (Left Atrial Hypertrophy, Primary Care Notebook/GPnotebook; Left Atrial Enlargement, LITFL, 2024)
• PR interval: within normal limits (0.12-0.20 s) unless a separate, coexisting conduction disturbance is present
• QRS complex: within normal limits unless left ventricular hypertrophy or another coexisting abnormality is also present — left ventricular hypertrophy voltage criteria often accompany this finding given their shared underlying causes, and in this dataset the majority of LAH-labeled records also carry a left ventricle hypertrophy label, but isolated pressure overload (as in mitral stenosis) can produce this P-wave finding with the left ventricle staying normal-sized or underfilled rather than hypertrophied (Mitral Stenosis, StatPearls, 2026; search-index.json record data, this dataset)
• ST segment: within normal limits; not a defining feature of this finding on its own
• T waves: within normal limits; not a defining feature of this finding on its own
• QT interval: within normal limits; not a defining feature of this finding
• Other findings: confirm P-wave amplitude stays normal — an amplitude increase alongside the widened duration points instead to a combined amplitude-and-duration (biatrial) abnormality rather than a pure left atrial finding; the P-wave duration criterion correlates imperfectly with true anatomic enlargement or hypertrophy on imaging even at its best-performing lead, so echocardiographic correlation is what actually establishes or excludes the diagnosis, not the strip alone (2025 study, cited above)

The defining ECG correlate, at any cause, is duration without amplitude: this is the same P-wave criterion used for P mitrale and for this dataset’s separate LAE label, so the strip cannot distinguish among the three — only echocardiography can confirm which anatomic finding, if any, is actually present.

Key Leads

• Lead II – Primary lead for the associated P-wave finding; the duration criterion (>120 ms) and notched/bifid morphology are assessed here, and this is the lead where the P-wave criterion best correlates with imaging-confirmed enlargement among the standard criteria, even though the same 2025 study still concluded ECG criteria for this finding need updating (2025 study, cited above)
• Lead V1 – Assesses the P wave’s terminal, left-atrial component; a widened and deepened terminal negative deflection supports the same finding, though this criterion correlates with imaging-confirmed enlargement more weakly than the lead II duration criterion does (2025 study, cited above)

Differential Diagnosis

• Left Atrial Enlargement (LAE) — this dataset’s separate label sharing the identical P-wave duration criteria; in this dataset’s records the two labels are mutually exclusive (no record carries both), which reflects the original reading clinician’s label choice rather than a distinguishable ECG feature, since imaging alone can separate wall thickening from chamber dilation
• Prolonged P Wave (PPW) — this dataset’s label for the ECG sign itself (P mitrale); LAH is one of the anatomic findings this sign is presumed to indicate, but none of this dataset’s LAH-labeled records separately carry a PPW label — a more pronounced disconnect between the anatomic and sign labels than this dataset shows on the right side of the heart, where most tall-P-wave-adjacent records do carry both labels together
• Left Ventricle Hypertrophy (LVH) — the companion ventricular finding, driven by the same pressure-overload states (hypertension, mitral and aortic valve disease) that produce LAH; distinguishing clue: LVH requires its own QRS voltage and axis criteria, which an isolated P-wave finding does not meet, and pure atrial-pressure-overload causes like mitral stenosis can produce LAH without it; in this dataset most LAH-labeled records also carry an LVH label
• Right Atrial Hypertrophy (RAH) — a different chamber’s finding built on amplitude rather than duration criteria (a tall, peaked P wave in the inferior leads, not a widened, notched one); height versus duration is the discriminator, though in this dataset most LAH-labeled records also carry an RAH label, suggesting many of this dataset’s LAH-labeled strips reflect combined right-and-left atrial disease rather than isolated left-sided pathology
• P Wave Change (PWC) — this dataset’s broader catch-all label for any altered P-wave morphology, including flattening, notching, or biphasic change; a PWC label does not by itself indicate the duration increase that specifically anchors LAH’s P-wave criterion, and PWC does not co-occur with LAH in this dataset’s matching records

Treatment Brief

Left atrial hypertrophy itself is not directly treated at the bedside — it is a structural finding, and management targets whatever is driving the underlying left atrial pressure or volume load.

• Confirm lead placement and calibration, and repeat the strip if the P-wave pattern is new or unexpected, before accepting the duration measurement.
• Compare against a prior ECG when available — a longstanding, unchanged pattern in an asymptomatic patient is reassuring, while a new one warrants further evaluation.
• Correlate clinically, and with echocardiography when the finding is new or otherwise unexplained, rather than treating the ECG pattern as confirmation of true left atrial hypertrophy — even its best-performing lead correlates only imperfectly with imaging-confirmed enlargement, so a normal-appearing P wave does not exclude it either.
• Evaluate for an underlying driver: blood pressure control and hypertension workup, mitral valve evaluation, assessment for left ventricular hypertrophy or diastolic dysfunction, and review of aortic stenosis or hypertrophic cardiomyopathy history where relevant.
• Watch for and report new atrial arrhythmias — left atrial hypertrophy is a recognized substrate for atrial fibrillation, and the two conditions can reinforce each other over time.
• Note whether the pattern appears alongside left ventricular hypertrophy criteria or arises from a comparatively pure pressure-overload cause like mitral stenosis — both help distinguish a likely combined left-heart process from a primarily isolated one, and in this dataset LAH also co-occurs frequently with right-sided hypertrophy labels, which is worth noting as a possible marker of multi-chamber disease rather than isolated left atrial pathology.